Manage episode 272097942 series 1947483
On this episode, we revisit the management of of dyslipidemia. We review the basic pathophysiology of atherosclerosis and the four statin treatment groups. We also discuss where ezetimibe and PCSK9 inhibitors fit into the treatment regimens. We close with an overview of the EVAPORATE trial with icosapent ethyl (Vascepa) and the bempedoic acid (Nexletol) CVOT called CLEAR Outcomes.Thanks for listening!
If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable Power Point slides for each lecture. You can find our account at the website below:
If you have any questions for Cole or me, reach out to us on any of the following:
Text - 415-943-6116
Mike - email@example.com Cole - firstname.lastname@example.org
Instagram and other social media platforms - @corconsultrx
This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.